dc.contributor.author | Pakhchanian, Haig | |
dc.contributor.author | Kardes, Sinan | |
dc.contributor.author | Kuzu, Ali Suat | |
dc.contributor.author | Karagulle, Mine | |
dc.contributor.author | Raiker, Rahul | |
dc.date.accessioned | 2021-03-04T13:11:01Z | |
dc.date.available | 2021-03-04T13:11:01Z | |
dc.identifier.citation | Kardes S., Kuzu A. S. , Pakhchanian H., Raiker R., Karagulle M., "Population-level interest in anti-rheumatic drugs in the COVID-19 era: insights from Google Trends", CLINICAL RHEUMATOLOGY, 2020 | |
dc.identifier.issn | 0770-3198 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_7b08c221-3afb-4392-bfe3-4dee50119884 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/84257 | |
dc.identifier.uri | https://doi.org/10.1007/s10067-020-05490-w | |
dc.description.abstract | Introduction/objective The general public may utilize online information through search engines for implications and risks of some anti-rheumatic drugs. These drugs have been used in the management of coronavirus disease 2019 (COVID-19) and associated inflammatory sequelae or cytokine storm of infection. Therefore, the objective of this study was to investigate the population-level interest in anti-rheumatic drugs during the COVID-19 era, by analyzing changes in Google search frequency data. | |
dc.language.iso | eng | |
dc.subject | İç Hastalıkları | |
dc.subject | Klinik Tıp | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Tıp | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | İmmünoloji ve Romatoloji | |
dc.subject | ROMATOLOJİ | |
dc.title | Population-level interest in anti-rheumatic drugs in the COVID-19 era: insights from Google Trends | |
dc.type | Makale | |
dc.relation.journal | CLINICAL RHEUMATOLOGY | |
dc.contributor.department | İstanbul Üniversitesi , İstanbul Tıp Fakültesi , Dahili Tıp Bilimleri Bölümü | |
dc.contributor.firstauthorID | 2358211 | |